Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Chile Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20191
20202
20212
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Completed3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Akero Therapeutics, Inc1
AstraZeneca1
Galectin Therapeutics Inc.1
Galmed Research and Development, Ltd.1
Genfit1
Inventiva Pharma1
Novartis Pharmaceuticals1
Pontificia Universidad Catolica de Chile1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease11
Fibrosis4
Liver Cirrhosis2
Liver Diseases2
Cholelithiasis1
Diabetes Mellitus1
Esophageal and Gastric Varices1
Fatty Liver1
Hypertension, Portal1
Obesity1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.